Granahan Investment Management’s Strata Critical Medical Inc SRTA Stock Holding History

Granahan Investment Management’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.65M	Buy	+503,005	New	+$2.65M	0.09%	134

Other funds holding SRTA

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

PLC

Pillsbury Lake Capital San Francisco, California $366M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Granahan Investment Management's SRTA Position: Q2 2026 in Review

Granahan Investment Management opened a new position in Strata Critical Medical Inc (SRTA) in Q2 2026: 503,005 shares worth $2.65M. The stake represents 0.09% of the portfolio and ranks #134 among its holdings.

139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

Granahan Investment Management held 503,005 shares of Strata Critical Medical Inc worth $2.65M as of Q2 2026.
Strata Critical Medical Inc was a new Granahan Investment Management position in Q2 2026.
Strata Critical Medical Inc made up 0.09% of Granahan Investment Management's portfolio in Q2 2026, its #134 holding.
139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Granahan Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.